Screener
Amneal Pharmaceuticals, Inc. AMRX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of debt | 134,673 | — |
| Payments of deferred financing and refinancing costs | (1,982) | (1,745) |
| Borrowings on revolving credit facilities | 100,000 | 218,000 |
| Proceeds from exercise of stock options | 80 | 754 |
| Employee payroll tax withholding on restricted stock unit and performance stock unit vesting | (44,481) | (21,828) |
| Tax and other distributions to non-controlling interests | (21,067) | (24,958) |
| Proceeds from alliance party | 510 | — |
| Acquisition of non-controlling interest | (400) | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s stock issuance proceeds?
- Amneal Pharmaceuticals, Inc. (AMRX) reported stock issuance proceeds of $42K in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s stock issuance proceeds decreased by 93.9% year-over-year, from $685K to $42K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s stock issuance proceeds has grown at a 23.1% compound annual growth rate (CAGR), from $853K to $1.96M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Amneal Pharmaceuticals, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude